What Happened?
Cambridge, -based Goldfinch-Bio Resigned Robin Walker as Chief Legal Officer
Date of management change: October 04, 2022
Cambridge, -based Goldfinch-Bio Resigned Robin Walker as Chief Legal Officer
Goldfinch Bio is a biotechnology company that is singularly focused on discovering and developing precision therapies for kidney disease. Just as the goldfinch was a prominent figure of the Renaissance, Goldfinch Bio is leading a new age of therapeutic discovery to transform the treatment paradigm for patients with kidney disease. Goldfinch is integrating breakthroughs in kidney genetics and biology to identify new therapeutic targets and advance first-in-class drug candidates to treat patients with kidney disease. Our Product Engine will industrialize the integration of genetics and kidney biology and confer a differentiated ability to identify, validate, and pursue novel therapeutic targets to treat progressive kidney disease. At Goldfinch, we`re pioneering a new approach to discover and develop therapeutics that target the molecular basis of kidney disease. We`re looking for teammates who relish the challenge, and are compelled to leave a positive mark on the lives of colleagues and patients alike.
Robin Walker is Chief Legal Officer and Corporate Secretary at Areteia Therapeutics. Previously, Robin held various senior legal leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Gupta Puja, Rushenberg Tim, Denis Kris, Carozza Amanda, Delune Michael, Coleman Elizabeth, DeFelice Thomas, Hirigoyen Ignacio, Betouin Faustine, Cantelo Darleen, Sweeney Carol
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.